Affordable Access

Publisher Website

Consensus document: management of heart failure in type 2 diabetes mellitus.

Authors
  • Kaul, Upendra1
  • Ray, Saumitra2
  • Prabhakar, D3
  • Kochar, Arun4
  • Sharma, Kamal5
  • Hazra, Prakash Kumar6
  • Chandra, Subhash7
  • Solanki, Dharmesh Ramakant Bhai8
  • Dutta, Anjan Lal9
  • Kumar, Viveka10
  • Rao, M Srinivas11
  • Oomman, Abraham12
  • Dani, Sameer13
  • Pinto, Brian14
  • Raghu, T R15
Type
Published Article
Journal
Heart failure reviews
Publication Date
Aug 31, 2021
Volume
26
Issue
5
Pages
1037–1062
Identifiers
DOI: 10.1007/s10741-020-09955-7
PMID: 32447488
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

Type 2 diabetes mellitus (T2DM) is a known predisposing factor for heart failure (HF). The growing burden of these two conditions and their impact on health of the individual and on society in general needs urgent attention from the health care professionals. Availability of multiple treatment choices for managing T2DM and HF may make therapeutic decisions more complex for clinicians. Recent cardiovascular outcome trials of antidiabetic drugs have added very robust evidence to effectively manage subjects with this dual condition. This consensus statement provides the prevalence trends and the impact of this dual burden on patients. In addition, it concisely narrates the types of HF, the different treatment algorithms, and recommendations for physicians to comprehensively manage such patients. © 2020. Springer Science+Business Media, LLC, part of Springer Nature.

Report this publication

Statistics

Seen <100 times